OpenHealth Q&A

Get answered by medical professionals

Understanding Bioavailable Testosterone and Muscle Weakness: Seeking Insight

3/23/2025, 11:30:32 PMMale25-34

I would appreciate some clarity on the distinctions between bioavailable testosterone and other types, as well as potential reasons for its low levels—alongside my recurring deficiency in amino acids. Despite regularly consuming chicken or turkey with every meal, this marks the second instance of low amino acid levels for me. Currently, my total testosterone level rests at 230. Historically, the highest reading I've recorded is 330. Meanwhile, my bioavailable testosterone stands at 109, which the laboratory indicates is just shy of the normal range. Additionally, I’m noticing that four or five of my amino acids are below optimal levels. Over the past few years, I’ve observed that my muscle mass has begun to diminish rather than grow, even with consistent exercise, since I was 23 years old (now I’m 30). Alongside this, I have experienced significant fluctuations in blood pressure and heart rate, which once led to an alarming weight loss of 80 pounds over the span of a year. This was attributable to continuous tachycardia, persisting even at rest, which severely impacted my muscle strength, making daily movements difficult. Despite numerous visits to various doctors, often landing me in the emergency room, many tests returned seemingly 'normal' results. In the end, I was diagnosed with conversion disorder, and two years on psychiatric medication yielded no improvements. Just a month ago, my blood pressure began dropping to dangerously low levels, around 82/58, particularly when attempting to rest. This month, however, I faced a sudden spike, hitting 206/115, accompanied by temporary loss of vision in my right eye. Subsequently, a neurologist identified my condition as postural orthostatic tachycardia syndrome (POTS), and I found relief with a 10mg dose of propranolol, which significantly improved my mobility and addressed the tachycardia. Now, although those specific issues appear somewhat controlled, I still need to follow up with neurology, including tests like an EMG and transcranial Doppler, to explore my ongoing muscle challenges, which may have circulatory roots. It's also probable that I will need to consult with an endocrinologist or urologist regarding my persistently low hormone levels, which have been evident since I fell ill at 23. I’m hoping for insights on what could be happening with my health. Notably, during my earlier episodes with tachycardia and blood pressure issues, I observed a steady rise in my prolactin levels over two years, only to see them decline later on—a brain tumor was ruled out. My results showed a positive ANA (1:80), a negative myositis panel, and no signs of arthritis or abnormal amylase and lipase levels. Although my TSH levels are typically normal, I had an exception on one occasion. Is it conceivable that my issues are primarily hormonal rather than stemming from neurological, autonomic, or circulatory origins? This debilitating weakness hampers my mobility to the point where I struggle to walk unassisted, despite the fact that individuals significantly older than me, like my great-grandfather who reached 104, manage much better. This isn’t just typical muscle weakness; it's a state where I'm physically unable to support myself, plagued by constant muscle twitching and unable to join my wife on outings. It’s incredibly frustrating because the new healthcare providers I’ve encountered after relocating insist on attributing my condition to diet and exercise. Yet, I have communicated to them that previous workout efforts—combined with tachycardia—intensified my muscle pain, which is noticeably different from standard post-exercise soreness. Until recently, I never anticipated being told to rationalize my inability to sit up, stand, or maintain balance due to inactivity, especially when many heavier individuals live sedentary lives without such issues. For additional context, my CK levels remain within a normal range, and although my symptoms initiated at 23, it wasn’t until about three months into experiencing tachycardia that I started to lose functional capabilities; my legs were the first to be affected. Over a period of one year and three months marked by muscle weakness that progressed to my neck, I ultimately required a walker, and my heart rate while using it averaged around 150 bpm. What could potentially be inhibiting not just my muscle development but leading to further weakness since my vital signs were mostly stabilized two weeks ago?

Thyroid DisordersEndocrinologyRheumatology

Answers (1)

Cony

3/23/2025, 11:30:50 PM

OpenHealth AI

It sounds like you're facing a complex health situation with multiple interconnected challenges. Key aspects include low testosterone levels, muscle weakness, fluctuating blood pressure, and the recent diagnosis of postural orthostatic tachycardia syndrome (POTS). Let’s break this down for clarity and consider actionable steps.

Key Points:

  1. Bioavailable Testosterone vs. Total Testosterone:
    • Total Testosterone includes all testosterone in your blood, while bioavailable testosterone is the fraction that is not bound to proteins and is available for your body to use. Low bioavailable testosterone may contribute to muscle weakness.
  2. Muscle Weakness Causes:
    • Muscle weakness can stem from a variety of issues, including hormonal imbalances (like low testosterone), nutritional deficiencies (such as amino acids), and possibly neurological or circulatory factors, especially given your POTS diagnosis.
  3. Blood Pressure Variability:
    • Your history of fluctuating blood pressure suggests a need to continue monitoring these levels, as extreme highs and lows can affect overall health and muscle function.

Explanation:

Low testosterone can lead to decreased muscle mass and strength. Combined with low amino acids and your existing conditions, this may hinder your body's ability to maintain or build muscle effectively. Muscle twitching and severe weakness, especially after episodes of tachycardia, could indicate issues with muscle metabolism or nerve signals, further complicated by possible nutritional gaps, despite your protein intake.

Next Steps:

  1. Endocrine Evaluation:

    • Seek a referral to an endocrinologist if you haven't done so already. They can help evaluate your hormonal levels, including testosterone and prolactin, and assess potential treatments.
  2. Nutritional Assessment:

    • Consider speaking with a registered dietitian to ensure you meet your amino acid needs optimally. You may need to evaluate the forms of protein you are consuming and whether they meet your specific requirements based on your health status.
  3. Muscle and Neurological Follow-Up:

    • Continue follow-ups with your neurologist regarding muscle issues and complete the additional tests (like EMG and transcranial Doppler). These will provide deeper insights into whether your muscle weakness has a neurological base.
  4. Blood Pressure Monitoring:

    • Keep track of your blood pressure at home, especially changes in response to posture and activities. If you notice significant fluctuations, report these to your healthcare provider.
  5. Gentle Exercise:

    • Under the guidance of a physical therapist or rehabilitation specialist, explore adapted physical activities that do not exacerbate your symptoms. This may help maintain muscle function and improve strength without undue strain.
  6. Support System:

    • Engage with support groups or forums where you can share your experiences. Connecting with others facing similar challenges can provide emotional support and practical advice.

Summary:

Your health journey is complex, involving multiple systems and factors. It's crucial to prioritize communication with your healthcare team about your symptoms and any changes you observe. Your condition is not just a matter of inactivity or diet; it requires a comprehensive, multidisciplinary approach. Remember to be proactive and advocate for your health needs as you navigate this challenging situation.

Related Questions

Understanding EEG Results for My 22-Month-Old Son: Insights Needed

Could someone help clarify this for me? My son, who is just 22 months old, hasn’t started walking yet, becomes tired easily, and has been experiencing behavioral outbursts. He had a febrile seizure in February 2025, followed by another unexplained seizure in April 2025, which led us to consult a neurologist. Since he was 3 months old, he has been receiving therapy from a physical therapist for torticollis. At birth, he spent five days in the NICU due to issues with meconium aspiration. A recent MRI showed normal results, and he also had a follow-up EEG after one conducted in July 2025. The results from this recent EEG were abnormal for a pediatric patient in awake, drowsy, and sleeping states. Notably, there were brief episodes of left frontotemporal delta slowing, which occurred mainly when he was awake and drowsy. There were no signs of epileptiform activity detected. In contrast, the EEG performed back on July 3, 2025, was deemed normal for both awake and drowsy states, again with no evidence of epileptiform irregularities, although it did not capture any sleep data. This examination was prompted by the child's existing history of febrile seizures. Importantly, he is not currently on any anti-seizure medications. The EEG procedure used standard electrode placements per the 10-20 system, conducted a single-lead EKG, and included continuous video monitoring. During the analysis, the background activity was symmetric, indicating some anterior-posterior (AP) organization, with a dominant rhythm of 50-80 microvolts at 7 Hz. His drowsy state was marked by a reduced amount of eye blink activity, less breathing motion interference, and a generalized slowing in theta/delta frequencies. Stage II sleep exhibited spindles and vertex waves patterns. Additionally, there were intermittent bursts of 250-300 microvolts in the left frontotemporal region with semi-rhythmic activity of 2-4 Hz, mostly observed during wakefulness and drowsiness. No definitive epileptiform discharge was noted. Photic stimulation during the test did not elicit a strong response, and hyperventilation was not conducted during this session.

Multiple SclerosisCrohn's DiseaseEndocrinology
Male25-34
50 minutes ago

INTENSE Spine Discomfort, Breathing Difficulties, Muscle Twitches, and Sweating

To elaborate on the situation mentioned in the title, I’ve been experiencing unusual muscle twitches and spasms for the past few days, along with some discomfort in my back. However, today, I felt an unexpected sharp pain shoot through my spine, which has left my legs feeling numb and made it impossible for me to sit up straight. Additionally, I’ve been dealing with cold sweats for the last hour and struggling to breathe properly. Perhaps I’m just overanalyzing things and it’s a common occurrence, but the intensity of the pain is overwhelming—it's truly unbearable. I’m shaking quite a bit, and unfortunately, my parents aren’t responding to my attempts to reach them for help. I have a history of a chronic heart condition and arthritis, yet I’ve never experienced pain this severe, especially in my spine. For context, I am nearly 15 years old and female. My current medications include pain relievers, anxiety medication, beta blockers, and some vitamins, though those specifics may not be particularly relevant. I don’t smoke; however, I have tried vaping a few times, which might not matter much, but I thought it was worth mentioning as it was requested.

ArthritisCOPDRheumatology
Male25-34
1 hour ago

Understanding Atrial Fibrillation and Thyroid Issues: Variability in Cardioversion Decisions

Hello everyone, I’m reaching out for guidance regarding my mother’s current health situation, and I’d greatly appreciate any shared experiences or thoughts. **My mother's background:** - **Age**: 55 years - **Weight**: Recently dropped to 116 kg from 118 kg in just two days, likely due to diuretics. - **Health history**: Previously an underactive thyroid, undiagnosed and untreated, now presenting as overactive. - **Medications**: Currently taking thyroid medication and a beta-blocker (Rapiblock). **Current health status:** My mother has been hospitalized since Tuesday, experiencing **atrial fibrillation with heart rates exceeding 200** beats per minute due to her thyroid's hyperactivity. - The plan for cardioversion was initially settled on Tuesday. However, the following day, the medical team advised postponing it until her thyroid levels could be stabilized, believing that her heart rate would return to normal once her thyroid condition was managed. - Her **obesity** precludes her from undergoing a transthoracic echocardiogram, and due to her thyroid concerns, she cannot handle contrast dye (this has been a consistent issue for over four years). Therefore, the only feasible option was a **transesophageal echocardiogram (TEE)**, which has yet to be performed. - She has been prescribed various medications including beta-blockers and thyroid treatments in the past. - On Friday, a doctor proposed proceeding with cardioversion; however, the attending senior physician objected. - Today (Saturday), another clinician has expressed a desire to move forward with cardioversion, having initiated a new medication, as the senior physician is unavailable. - **Communication has been unclear**, as we were notified of developments by a nurse rather than the physician in charge, causing confusion and anxiety. - Currently, only a **chest X-ray** is scheduled, and the TEE remains unaddressed. **My inquiries are as follows:** 1. Is it common for medical professionals to have varying opinions and frequently revise medication or treatment plans like cardioversion? 2. Is it safe to conduct cardioversion in the absence of a TEE? I presumed that this was a standard procedure to exclude the presence of blood clots. 3. Is it usual practice to have only a chest X-ray prior to moving ahead with cardioversion? 4. How typical is it for patients or their families to not be directly informed about treatment changes and learn about them through nursing staff instead? I recognize that this cannot substitute for professional medical advice. I’m simply trying to discern whether these circumstances are typical or if we should express our concerns more assertively with the healthcare facility. Thank you for your insights!

Thyroid DisordersEndocrinologyRheumatology
Male25-34
2 hours ago

28-Year-Old Male Experiencing Scalp Sensations Post-Amitriptyline Treatment

I am a 28-year-old man in generally good health, without any cardiac concerns. Approximately a month ago, I encountered intense pain localized to one side of my head, which was unresponsive to paracetamol. However, a single dose of a migraine treatment provided substantial relief. Following that, I began a regimen of amitriptyline, starting at a nightly dose of 10 to 25 mg. While my head pain has diminished significantly—by about 90 to 95%—I now experience occasional uncomfortable sensations on my scalp. These feelings include pins and needles, a cooling sensation, and some crawling feelings near my hairline and ears. There are fleeting moments where I feel brief throbs lasting a second, but I do not have any persistent headaches. To clarify, I do not experience any of the following: - Nausea - Weakness in my limbs - Numbness - Changes in my vision - Coordination difficulties - Seizures The symptoms I have are transient, shifting around and often intensifying when I become conscious of them or as the day progresses. I would like to know: Is it common to experience these sensations during the recovery stage following episodes of neuralgia or migraine-like discomfort? Additionally, could the amitriptyline potentially be causing these temporary paresthetic sensations? I am seeking some reassurance or advice on what is typically observed during this healing process. Thank you.

Multiple SclerosisCrohn's DiseaseEndocrinology
Male25-34
3 hours ago

7-Month-Old Child with Abernethy Malformation - Exploring Treatment Options

# 7-Month-Old Child with Abernethy Malformation - Exploring Treatment Options ## [7-Month-Old] Identified with Abernethy Malformation (Congenital Portosystemic Shunt) - Treatment Methods? **Age:** 7 months **Gender:** Female **Height:** Age-appropriate **Weight:** Currently 9 kg, was 2.8 kg at birth **Ethnicity:** Asian **Duration of Symptoms:** Present since birth **Location:** Uzbekistan **Pre-existing Health Issues:** Abernethy malformation (congenital portosystemic shunt), liver hemangiomas, chronic jaundice, anemia **Current Treatments:** Supportive management --- ## INITIAL PRESENTATION (June 2025 - July 2025) Our daughter arrived on **June 27, 2025**, presenting with: - Birth weight: **2.8 kg** - Marked jaundice (yellowing of skin and sclera) - Pale or clay-colored stools - **Bilirubin level: 245 μmol/L** (typically <20) An immediate ultrasound indicated multiple liver anomalies, initially thought to be hemangiomas. --- ## FIRST COMPREHENSIVE ASSESSMENT (August 1, 2025 - 1 Month Old) ### Multislice Computed Tomography (MSCT) with 3-Phase Contrast (August 1, 2025): **RESULTS:** - **Portocaval shunt size: 9.9 mm** (blood bypassing the liver into the inferior vena cava) - **Arteriovenous shunt size: 4.4 mm** - **Portal vein size: 6.1 mm** (patent) - **Three nodular cystic lesions** located in the perivascular area, with largest measuring 11.6×20.7 mm, enhancing during the venous phase - Liver features a heterogeneous architecture, exhibiting irregular enhancement - Gallbladder appears elongated and slightly enlarged - Other abdominal organs exhibit normal findings **RADIOLOGIST’S ASSESSMENT:** "Congenital portosystemic shunt indicative of Abernethy malformation; less likely arteriovenous malformation (AVM); cannot dismiss the possibility of localized liver lesions." **ADVICE:** Seek consultations with an abdominal and vascular surgeon. ### Blood Tests (August 1, 2025): **Complete Blood Count:** - WBC: 10.44 × 10⁹/L (normal range) - **RBC: 2.1 × 10¹²/L** (LOW - indicating severe anemia) - **Hemoglobin: 69 g/L** (CRITICALLY LOW; normal is 117-166) - Platelets: 403 × 10⁹/L (elevated) **Biochemistry Analysis:** - Urea: 1.80 mmol/L (normal) - Creatinine: 33.4 μmol/L (normal) - **ALT: >1000 IU/mL** (EXTREMELY HIGH - severe liver dysfunction) --- ## FOLLOW-UP IMAGING (December 16, 2025 - 5.5 Months Old) ### Liver Ultrasound: **RESULTS:** - Right lobe: 64 mm, left lobe: 43 mm - Liver capsule appears irregular and vague - **Parenchyma: heterogeneous, showing 7 hypo-isoechoic nodules** (sizes range from 11.5×10.7 mm to 17.6×15.4 mm) - Capsule features uneven contours - Blood flow noted during Doppler examination - No dilation in intrahepatic bile ducts - **Portal vein: 3.9 mm** (decreased from 6.1 mm - indicating improvement) - Common bile duct: 1.4 mm - Gallbladder: measures 43.7×9.2 mm (pear-shaped, wall thickness 2.0 mm, homogeneous, free of stones) **ULTRASOUND ASSESSMENT:** "Presence of liver volumetric formations (specifically liver hemangiomas)." --- ## LATEST MSCT (February 6, 2026 - 7 Months Old) ### MSCT with 3-Phase Contrast: **FINDINGS:** - Liver remains normal in size, but shows heterogeneous structure with uneven contrast enhancement - **Portocaval shunt: 9.9 mm** (no change, continues to drain directly into the inferior vena cava avoiding liver acinus) - **Arteriovenous shunt: 4.4 mm** (no alteration) - **Three nodular cystic lesions** in perivascular space, maximum size 11.6×20.7 mm, enhancing in the venous phase - **Portal vein: 6.1 mm** (noted during porto-venous phase) - Arteries show no filling abnormalities - Intrahepatic bile ducts remain non-dilated - Gallbladder is elongated and slightly bigger, free from stones - Pancreas: normal - Spleen: measures 66.9×38.5 mm (not enlarged), splenic vein is 3.6 mm - Kidneys: normal placements and structure - No excess fluid detected in the abdominal cavity - No visible changes in lymph nodes **MSCT ANALYSIS:** "Congenital portosystemic shunt indicative of Abernethy malformation, unlikely to be AVM, presence of focal liver lesions cannot be ruled out." **RECOMMENDATION:** Engage with an abdominal and vascular surgeon. --- ## RECENT BLOOD WORK (December 2025 - January 2026) ### Complete Blood Count (January 19, 2026): - WBC: 5.8 × 10⁹/L (SHOWS IMPROVEMENT) - **RBC: 2.93 × 10¹²/L** (IMPROVED but still low) - **Hemoglobin: 72 g/L** (SHOWS IMPROVEMENT but still low) - Platelets: 223 × 10⁹/L (BACK TO NORMAL) - Neutrophils: 30.0% - Lymphocytes: 64.8% - Monocytes: 4.6% ### Biochemistry (January 28, 2026): - Total protein level: 67 g/L (slightly deficient) - Creatinine: 20.7 μmol/L - **Total Bilirubin: 242 μmol/L** (STILL HIGH - unchanged) - **Direct Bilirubin: 142 μmol/L** (VERY HIGH) - **ALT: 50 IU/mL** (DRASTICALLY LOWER from >1000!) --- ## OVERVIEW OF PROGRESS OVER 6 MONTHS | Parameter | August 2025 | January 2026 | Change | |------------------|-------------|---------------|--------------------------| | **Hemoglobin** | 69 g/L | 72 g/L | ↗ Slight improvement | | **RBC** | 2.1 | 2.93 | ↗ Improved | | **ALT** | >1000 | 50 | ✓✓ MAJOR IMPROVEMENT | | **Bilirubin** | 245 | 242 | → Unchanged (still elevated) | | **Portal vein** | 6.1 mm | 3.9 mm (US) | ↗ Decreased | | **Platelets** | 403 | 223 | ↘ Normalized | | **Shunt size** | 9.9 mm | 9.9 mm | → No Change | --- ## CURRENT SITUATION (February 2026 - 7 Months Old) - **Weight:** 9 kg (good growth rate in spite of condition) - **Jaundice:** Continues to be present (yellow skin) - **Stools:** Remain pale/clay-colored - **Development:** Achieving appropriate milestones - **Energy:** Appears to have a good energy level - **Feeding:** Normal appetite --- ## QUESTIONS FOR r/AskDocs We have been informed this is **Type 2 Abernethy malformation** (portal vein present). **Three treatment avenues have been proposed:** ### Option 1: **Endovascular Coil Embolization** (minimally invasive approach) - A catheter is inserted via the leg vein to access the shunt and deploy coils/plugs to close the abnormal vessels - Pros: No surgical incision, minimal discomfort, short hospital stay (2-4 days), no scars, enhanced safety - Duration: 1-2 hours - Recovery: 2-4 weeks for jaundice to show improvement ### Option 2: **Open Surgical Intervention** - An incision in the abdomen to ligate abnormal vessels and redirect blood to the liver - Pros: Direct visualization, effective results - Cons: Surgical scar, longer recovery time (7-14 days in hospital) - Duration: 2-4 hours ### Option 3: **Liver Transplantation** - We have been advised this is not necessary as the portal vein is functional and liver health is improving. --- ## SPECIFIC QUESTIONS TO CONSIDER: 1. **With a functional portal vein (6.1 mm) and improving liver function (ALT normalized), is it advisable to pursue endovascular closure as the preferred treatment?** 2. **Despite ALT levels improving, the bilirubin remains consistently high (242). Should this be a cause for concern? Is there a prospect for it to normalize post shunt closure?** 3. **Are the hemangiomas/nodules (11.6×20.7 mm) linked to the shunt? Will they likely resolve following shunt repair?** 4. **How urgent is the proposed intervention? Is immediate action required, or is there flexibility to wait a few months?** 5. **What complications should we be vigilant for during the waiting period?** 6. **Regarding endovascular closure - what is the average success rate for infants aged 7 months? Are there concerns regarding the shunt size (9.9 mm)?** 7. **The measurement of the portal vein has shown improvement from 6.1 mm to 3.9 mm; should this be perceived as a positive sign or a reason for concern?** 8. **Are there special directives (diet modifications, medications) we should consider while awaiting the procedure?** 9. **Post-procedure, how long should we expect it might take for:** - Normalization of bilirubin levels? - Return of stool color to normal? - Resolution of jaundice? - Regression of hemangiomas? 10. **Can you recommend any specialized centers for pediatric Abernethy malformation treatments? We are located in Uzbekistan but are prepared to travel (to Turkey, Russia, South Korea, etc.)** --- ## ADDITIONAL INFORMATION - No family history of hepatic diseases - Pregnancy and delivery were normal - No additional congenital defects identified - Immunizations up to date - No history of bleeding disorders - No signs indicative of encephalopathy - Child is alert and engaged --- **I can supply actual MSCT images and comprehensive lab reports if they would be of assistance.** We sincerely appreciate any insights you can provide. We are striving to make the most informed decision regarding our daughter’s care and highly value expert medical opinions. **TL;DR:** 7-month-old diagnosed with Abernethy Type 2 malformation (9.9 mm portocaval shunt, patent portal vein). Liver functionality is improving (normalized ALT) while bilirubin remains elevated (242). Evaluating options between endovascular coil embolization and open surgery. Seeking expert advice on optimal treatment strategy and timing.

Thyroid DisordersInternal MedicineEndocrinology
Male25-34
3 hours ago